|
MechanismHLA-DR antigens-associated invariant chain modulators [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with CD74 x Top I
100 Translational Medicine associated with CD74 x Top I
0 Patents (Medical) associated with CD74 x Top I